MAPK3 and cancer: Specifically, the Raf-Ras-MEK1/2-ERK1/2 signaling pathway can promote tumorigenesis while the p38 mitogen activated protein kinases pathway (MAPK) suppresses cancer through oncogene-induced senescence, inflammation-induced senescence, contact inhibition, and DNA damage responses (79, 80).